The U.S. Food and Drug Administration has expanded its approval of the anticonvulsant Diacomit (stiripentol) — when used as…
Articles by Marisa Wexler, MS
There are close statistical associations between seizure frequency and the severity of other disease symptoms, such as language problems, in people…
Japan’s Ministry of Health, Labour and Welfare has approved oral Fintepla (fenfluramine) as an add-on treatment for seizures associated…
Treatment with soticlestat significantly reduced seizure frequency for children with Dravet syndrome or Lennox-Gastaut syndrome (LGS), another childhood…
Adults with Dravet syndrome commonly experience walking difficulties that tend to worsen with age, a small study reports. “In…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Eight adults with lifelong histories of epilepsy and developmental delays without any known cause were diagnosed with Dravet syndrome…
Vaccines for COVID-19 are generally safe for children with Dravet syndrome, and are unlikely to cause an increase in…
Treatment with STK-001, Stoke Therapeutics‘ investigational therapy for Dravet syndrome, has so far raised no safety concerns among…
Longboard Pharmaceuticals is planning to launch a Phase 1b/2a clinical trial early next year that will evaluate the company’s…